Tivadar Bara Selected Research

Liposarcoma

1/2015

Relationship of endothelial area with VEGF-A, COX-2, maspin, c-KIT, and DOG-1 immunoreactivity in liposarcomas versus non-lipomatous soft tissue tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tivadar Bara Research Topics

Disease

18	Neoplasms (Cancer) 02/2021 - 01/2014
6	Stomach Neoplasms (Stomach Cancer) 01/2020 - 03/2015
6	Neoplasm Metastasis (Metastasis) 03/2019 - 01/2014
4	Adenocarcinoma 12/2019 - 05/2016
3	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 09/2017
3	Lymphatic Metastasis 02/2020 - 08/2017
3	Carcinoma (Carcinomatosis) 06/2019 - 09/2014
3	Incisional Hernia 09/2016 - 05/2007
2	Intra-Abdominal Hypertension 10/2018 - 02/2017
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2017 - 01/2015
2	Hernia (Hernias) 09/2016 - 05/2007
2	Microsatellite Instability 05/2014 - 02/2013
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Breast Ductal Carcinoma 01/2018
1	Lobular Carcinoma 01/2018
1	Ductal Carcinoma 01/2018
1	Wounds and Injuries (Trauma) 02/2017
1	Cysts 09/2016
1	Postoperative Pain 09/2016
1	Obesity 09/2016
1	Carcinogenesis 05/2016
1	Metaplasia 05/2016
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015
1	Dermatofibrosarcoma 01/2015
1	Liposarcoma 01/2015
1	Rectal Neoplasms (Rectal Cancer) 09/2014
1	Clear Cell Adenocarcinoma 01/2014
1	Cicatrix (Scar) 05/2007

Drug/Important Bio-Agent (IBA)

11	SERPIN-B5 (maspin)IBA 02/2020 - 05/2014
7	Cadherins (E-Cadherin)IBA 02/2021 - 01/2015
4	CateninsIBA 02/2021 - 01/2018
4	VimentinIBA 02/2020 - 09/2015
4	Carcinoembryonic AntigenIBA 01/2019 - 01/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 05/2014
4	Proteins (Proteins, Gene)FDA Link 08/2017 - 01/2015
4	Keratins (Keratin)IBA 01/2015 - 01/2014
3	AntibodiesIBA 01/2020 - 05/2016
3	Indicators and Reagents (Reagents)IBA 01/2020 - 09/2014
3	Phosphopyruvate Hydratase (Enolase)IBA 01/2019 - 05/2014
3	SynaptophysinIBA 01/2019 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 02/2021 - 09/2017
2	Calcibiotic Root Canal SealerIBA 02/2020 - 09/2017
2	Keratin-7 (Cytokeratin 7)IBA 09/2016 - 05/2014
2	Polypropylenes (Polypropylene)IBA 09/2016 - 05/2007
2	AntralIBA 09/2015 - 01/2015
1	human ERBB2 proteinIBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	Coloring Agents (Dyes)IBA 03/2019
1	SolutionsIBA 10/2018
1	Estrogen ReceptorsIBA 01/2018
1	Keratin-20 (Cytokeratin 20)IBA 09/2016
1	Calbindin 2IBA 09/2015
1	Inhibins (Inhibin)IBA 09/2015
1	ParaffinIBA 09/2014
1	MucinsIBA 09/2014
1	Keratin-5 (Keratin 5)IBA 05/2014
1	Mucin-1 (CA 15-3 Antigen)IBA 05/2014
1	ChromograninsIBA 05/2014
1	Codon (Codons)IBA 02/2013

Therapy/Procedure

12	Therapeutics 02/2021 - 01/2014
5	Laparotomy 10/2018 - 05/2007
2	Chemoradiotherapy 06/2019 - 09/2014
1	Conservative Treatment 10/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Gastrectomy 01/2018
1	Mastectomy (Mammectomy) 01/2018
1	Decompression 02/2017
1	Pancreatectomy 09/2016
1	Splenectomy 09/2016
1	Radiotherapy 09/2014
1	Metastasectomy 01/2014